EirGenix (TPE:6589) Other Current Liabilities: NT$387 Mil (As of Dec. 2025)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

TPE:6589 EirGenix Inc TPE:6589
58 GF Score
Price NT$46.25
GF Value NT$93.18
Valuation Possible Value Trap
! 6 Warning Signs
View Full Analysis

What is EirGenix Other Current Liabilities?

EirGenix TPE:6589 -2.22% 58 Other Current Liabilities is NT$387 Mil as of Dec. 2025. GuruFocus rates TPE:6589 with a GF Score™ of 58/100 and a GF Value™ of NT$93.18 (Possible Value Trap). The stock has 6 warning signs investors should review.

EirGenix's other current liabilities for the quarter that ended in Dec. 2025 was NT$387 Mil.

EirGenix's quarterly other current liabilities declined from Jun. 2025 (NT$176 Mil) to Sep. 2025 (NT$135 Mil) but then increased from Sep. 2025 (NT$135 Mil) to Dec. 2025 (NT$387 Mil).

EirGenix's annual other current liabilities declined from Dec. 2023 (NT$60 Mil) to Dec. 2024 (NT$50 Mil) but then increased from Dec. 2024 (NT$50 Mil) to Dec. 2025 (NT$387 Mil).

EirGenix Other Current Liabilities Related Terms

EirGenix Other Current Liabilities Historical Data

* Premium members only.

The historical data trend for EirGenix's Other Current Liabilities can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

EirGenix Other Current Liabilities Chart

EirGenix Annual Data
Trend Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
Other Current Liabilities
Get a 7-Day Free Trial Premium Member Only Premium Member Only 228.89 153.58 59.70 49.79 387.34

EirGenix Quarterly Data
Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25
Other Current Liabilities Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 49.79 144.13 176.40 135.28 387.34
TPE:6589
58GF Score
EirGenix Inc TPE:6589
Other Current Liabilities is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

EirGenix Other Current Liabilities Calculation

The liability a company needs to pay in the next 12 months, but not assigned to Accounts Payable or Debt. For instance, Wal-Mart (WMT) has accrued wages, salaries, valuation, bonuses, insurance liabilities, accrued tax etc. These are all included in other current liabilities.

What does a Other Current Liabilities of NT$387 Mil mean?
EirGenix (TPE:6589) has a Other Current Liabilities of NT$387 Mil as of Dec. 2025. Other current liabilities as record on a company's balance sheet not categorized as standard liabilities. View historical data on EirGenix.
Is EirGenix's Other Current Liabilities too high?
EirGenix's current Other Current Liabilities is NT$387 Mil. Overall, EirGenix has a GF Score™ of 58/100 and is considered Possible Value Trap, reflecting its overall financial health beyond just this single metric.
How does EirGenix's Other Current Liabilities compare to VRTX and REGN?
EirGenix's Other Current Liabilities of NT$387 Mil can be compared against companies in the Biotechnology industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Other Current Liabilities for a Biotechnology company?
A good Other Current Liabilities depends on the Biotechnology industry context. However, Other Current Liabilities should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Other Current Liabilities mean?
A high Other Current Liabilities can signal that a stock is expensive relative to its fundamentals. Other current liabilities as record on a company's balance sheet not categorized as standard liabilities. View historical data on EirGenix. EirGenix's current Other Current Liabilities is NT$387 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is EirGenix stock overvalued right now?
Based on GuruFocus' analysis, EirGenix (TPE:6589) is currently considered Possible Value Trap. The stock's GF Value™ is NT$93.18, compared to a current price of NT$46.25 — trading 50.4% below its estimated fair value. The current Other Current Liabilities is NT$387 Mil. EirGenix's overall GF Score™ is 58/100 with 6 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Other Current Liabilities calculated?
Other Current Liabilities is calculated from a company's financial statements. For EirGenix (TPE:6589), the current Other Current Liabilities is NT$387 Mil as of Dec. 2025. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is EirGenix (TPE:6589) Overvalued in 2026?

Based on GuruFocus' analysis, EirGenix stock appears to be undervalued. The current stock price of NT$46.25 is trading 50.4% below its estimated GF Value™ of NT$93.18. GuruFocus considers EirGenix to be Possible Value Trap.

Key valuation signals for TPE:6589:

  • Other Current Liabilities: NT$387 Mil
  • GF Value™: NT$93.18 vs. price of NT$46.25 (50.4% below fair value)
  • GF Score™: 58/100 with 6 warning signs

No single metric tells the full story. See the TPE:6589 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

EirGenix Business Description

Address No. 101, Lane 169, Kangning Street, Xizhi District, New Taipei, TWN, 22180
EirGenix Inc is engaged in the research and development of biosimilars and new drugs, as well as biopharmaceutical contract development and manufacturing services, which included cell line construction platforms, process development platforms, analytical science and protein identification. Its products include CRM197 CARRIER PROTEIN, PRODUCT PIPELINE, COVID-19 ANTIGEN RAPID TEST. The revenue is derived from biopharmaceutical contract development and manufacturing services, sales of authorization and cooperative development, and sales of goods. Geographically, it operates in Japan, Taiwan, USA and Canada, Mainland China, Hong Kong, and Macao, and Europe, Others.
58GF Score

Get the complete analysis for TPE:6589

Other Current Liabilities is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

NT$46.25
Price
NT$93.18
GF Value